Localizing cancer treatment in Saudi Arabia: 80% cost reduction and better care

A national achievement that enhances healthcare for cancer patients

The Kingdom of Saudi Arabia has achieved a significant medical and economic milestone by successfully localizing advanced cancer treatment technologies, specifically CAR-T cell therapy, resulting in a reduction of treatment costs exceeding 80%. This qualitative advancement is part of a broader strategy aimed at enhancing the sustainability and efficiency of healthcare, in line with the objectives of the Kingdom's Vision 2030.

In this context, Dr. Nayef Al-Otaibi, Vice Dean of the College of Medicine and Director of the Center for Health Economics at Alfaisal University, confirmed that localizing this revolutionary treatment has reduced the cost of treating a single case from 1.3 million riyals to approximately 250,000 riyals. This enormous financial saving is not merely a reduction in spending, but a direct investment in the health of citizens, allowing the healthcare system to expand the base of beneficiaries of these advanced treatments, provide care to a larger number of cancer patients, and tangibly improve their quality of life.

General context: From expensive imports to leading domestic production

Historically, cellular and gene therapies, such as CAR-T cell therapy, were the preserve of a few leading medical centers worldwide. Like other countries, the Kingdom relied on sending patients abroad or importing treatments at exorbitant costs, placing a significant burden on the healthcare budget and limiting access for all patients in need. CAR-T cell therapy is an advanced form of immunotherapy in which a patient's immune cells are genetically modified in the laboratory to precisely target cancer cells. It has proven highly effective in treating certain types of blood cancers, such as leukemia and lymphoma.

The success of King Faisal Specialist Hospital and Research Centre in localizing this complex technology represents a strategic shift from dependence on foreign sources to achieving self-sufficiency and building national capabilities in the field of biotechnology and advanced pharmaceutical industries.

Importance and expected impact on various levels

The impact of this achievement extends far beyond simply providing care for patients within the Kingdom, as it shapes the future of healthcare at the local, regional, and international levels.

• At the local level, localizing treatment ensures faster and easier access for patients, reducing the psychological and physical burdens associated with traveling abroad for treatment. It also enhances the standing of Saudi medical and research professionals, creates quality job opportunities in the biotechnology sector, and supports the transition to a knowledge-based economy.
• At the regional level: This success places the Kingdom among the leading countries in the field of advanced medicine, and makes it a potential regional center for cancer treatment, which may open the door to medical tourism and attract patients from neighboring countries.
• At the international level: The Saudi model provides evidence of the possibility of successfully transferring and localizing complex medical technologies, inspiring other countries to follow the same approach to strengthen their health systems and achieve financial sustainability.

Towards a sustainable, value-based healthcare system

Dr. Al-Otaibi pointed out that this development is not an isolated case, but rather part of a comprehensive transformation within the Saudi healthcare system. Massive investments in research and innovation have led to significant advancements in other fields, such as robotic surgery and micro-endoscopy, all aimed at improving diagnostic accuracy and treatment effectiveness. This trend underscores the shift from the traditional healthcare model, based on the volume of services provided, to a "value-based healthcare" model. This model focuses on achieving the best possible health outcomes for patients while optimizing resource utilization, thus ensuring the development of a sustainable healthcare system capable of meeting future challenges.